Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-08-15Clinical Trial Update: Pioglitazone and Insulin Resistance in ADT [Phase 3]
Phase 3 trial evaluating pioglitazone for insulin resistance in the context of androgen deprivation therapy for prostate cancer has been wit…
-
CLINICAL_TRIALS withdrawal · 2023-08-04Clinical Trial Update: Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension [Phase 3]
Phase 3 trial (KEYNOTE-921) evaluating pembrolizumab with docetaxel versus placebo with docetaxel in chemotherapy-naïve metastatic castratio…
-
CLINICAL_TRIALS withdrawal · 2023-06-29Clinical Trial Update: BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy [Phase 3]
Phase 3 trial BioDFence G3 for full nerve-sparing robotic-assisted radical prostatectomy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-09-06Clinical Trial Update: Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy [Phase 2, Phase 3]
A clinical trial investigating an opioid-free pain control regimen following robotic radical prostatectomy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-03-29Clinical Trial Update: Trial of NanoPac Focal Therapy for Prostate Cancer [Phase 2]
A Phase 2 trial of NanoPac focal therapy for prostate cancer was terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-12-15Clinical Trial Update: Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer [Phase 2, Phase 3]
A clinical trial investigating 18F-DCFPyL PET/CT imaging for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-08-17Clinical Trial Update: Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer [Phase 3]
Phase 3 trial evaluating apalutamide with radiotherapy and androgen deprivation therapy in prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-24Clinical Trial Update: Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole
The trial investigating biomarkers in bone marrow and blood from prostate cancer patients treated with ketoconazole has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-22Clinical Trial Update: Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery [Phase 2]
A Phase 2 clinical trial evaluating bicalutamide and raloxifene hydrochloride in prostate cancer patients undergoing surgery has been withdr…
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging [NA]
A clinical trial evaluating imaging of prostate cancer using two-dimensional MR spectroscopy and diffusion tensor imaging has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy [Phase 2]
The Phase 2 trial evaluating ciprofloxacin versus placebo to aid in diagnosing prostate cancer in men undergoing prostate biopsy has been wi…
-
CLINICAL_TRIALS withdrawal · 2018-07-03Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer [NA]
A clinical trial evaluating omega-3 fatty acids for Stage III prostate cancer has been withdrawn (NCT00996749), sponsored by Wake Forest Uni…
-
CLINICAL_TRIALS withdrawal · 2018-04-20Clinical Trial Update: Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer [NA]
The clinical trial evaluating stereotactic body radiotherapy for metastatic prostate cancer has been withdrawn from the study registry.
-
CLINICAL_TRIALS withdrawal · 2017-12-13Clinical Trial Update: Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial of genistein in patients undergoing external-beam radiation therapy for bone metastases was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: Real-Time MV/kV Image Guided Radiation Therapy
A Stanford University-sponsored study evaluating real-time MV/kV image-guided radiation therapy for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-30Clinical Trial Update: Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating sipuleucel-T (Provenge) followed by docetaxel in castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-30Clinical Trial Update: Docetaxel Followed by Provenge in Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial of docetaxel followed by Provenge in metastatic prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-13Clinical Trial Update: Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer [NA]
A clinical trial investigating Choline PET/CT versus MeAIB PET/CT for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer [Phase 1]
Phase 1 trial evaluating hypo-fractionated radiation therapy for localized prostate cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management [Phase 2]
A Phase 2 clinical trial evaluating 68Ga-PSMA PET-CT for detection of prostate cancer recurrence and its impact on patient management has be…
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy [Phase 2]
Phase 2 trial evaluating vinorelbine plus paclitaxel for metastatic prostate cancer refractory to hormone therapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: Pre-Prostatectomy Celecoxib or Placebo [Phase 2]
A Phase 2 trial evaluating celecoxib versus placebo before prostatectomy was terminated.
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
The phase 1 S0716 trial of vandetanib in combination with docetaxel for patients with advanced solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-17Clinical Trial Update: Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
This clinical trial update notes the termination of a study evaluating molecular characterization of circulating tumor cells (CTCs) and circ…